|
|
Office Locations:
|
5800 Armada Drive, Suite 210
Carlsbad, CA 92008
Phone: 858-704-4900
| | |
|
|
|
|
|
Information Technology
Life Sciences & Healthcare
Medical Device
Software & Internet
|
|
|
|
Leading Biosciences (formerly Leading Ventures) provides capital for early stage bio-technology companies in the development phase, after proof of concept but pre-revenue, that can be accelerated to a revenue generating entity, early out-licensing or sale to an acquiring firm. Leading BioSciences was founded in 2005 based on research at University of California, San Diego and University of California, Irvine, and discoveries which were supported by more than $22,000,000 in funding from National Institutes of Health. Leading Biosciences' portfolio is primarily comprised of seed or first round investments with a focus on technology ventures in the areas including: Medical Devices, Biotech, Pharmaceuticals, Homeland Security, Software Solutions and other technologies. The company's product lines cover over a dozen disease conditions and an addressable market size of approximately $113 Billion.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
